Skip to content

Clinical study on the treatment of acute upper respiratory tract infection fever with intradermal acupuncture

Clinical study on the treatment of acute upper respiratory tract infection fever with intradermal acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000935
Enrollment
Unknown
Registered
2025-05-09
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute upper respiratory infection fever

Interventions

Blank control group:Do not intervene
Acupuncture antipyretic group:Take Dazhui point Quchi point Hegu point and Yuji point and use acupuncture and moxibustion needle acupuncture treatment. The patient exposes the skin of the acupoint are
Intradermal needle test group:Select Dazhui acupoint Quchi acupoint Hegu acupoint and Yuji acupoint and use intradermal needle application for treatment. The patient exposes the skin in the acupoint a

Sponsors

Dongzhimen Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Gender: No gender restrictions; 2) Age = 18 years old and = 80 years old; 3) Meets the diagnostic criteria for acute upper respiratory tract infection; 4) Underarm temperature = 37.3 ? while = 38.5 ?; 5) The patient has signed the informed consent form; 6) The patient did not self administer antipyretic drugs (arginine ibuprofen granules ibuprofen sustained-release capsules acetaminophen tablets etc.) within 6 hours

Exclusion criteria

Exclusion criteria: 1) Patients who are allergic to intradermal needle dressings and have an allergic constitution; 2) Patients with skin lesions and other skin problems at acupoints; 3) Patients with long-term chronic low-grade fever; 4) Patients with poor blood sugar control in diabetes; 5) Patients with poor control of hypertension and blood pressure; 6) Suffering from severe mental illness or unable to cooperate with this trial; 7) Pregnant and lactating women; 8) Symptoms of shortness of breath blood oxygen<93% (pneumonia patients)

Design outcomes

Primary

MeasureTime frame
temperature;

Secondary

MeasureTime frame
Heart rate;TCM symptom and sign scores (h0 h0.5 h1);Respiratory rate;

Countries

China

Contacts

Public ContactTian Li

Dongzhimen Hospital Beijing University of Chinese Medicine

leelee.1984@163.com13811235939

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026